RhumbLine Advisers’s GoHealth GOCO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.8K | Buy |
6,814
+2,527
| +59% | +$14K | ﹤0.01% | 3714 |
|
2025
Q1 | $52.6K | Buy |
4,287
+119
| +3% | +$1.46K | ﹤0.01% | 3563 |
|
2024
Q4 | $55.8K | Sell |
4,168
-245
| -6% | -$3.28K | ﹤0.01% | 3628 |
|
2024
Q3 | $41.4K | Sell |
4,413
-563
| -11% | -$5.28K | ﹤0.01% | 3714 |
|
2024
Q2 | $48.4K | Buy |
4,976
+63
| +1% | +$612 | ﹤0.01% | 3694 |
|
2024
Q1 | $51.6K | Sell |
4,913
-684
| -12% | -$7.19K | ﹤0.01% | 3620 |
|
2023
Q4 | $74.7K | Sell |
5,597
-186
| -3% | -$2.48K | ﹤0.01% | 3539 |
|
2023
Q3 | $83.8K | Buy |
5,783
+253
| +5% | +$3.67K | ﹤0.01% | 3516 |
|
2023
Q2 | $109K | Buy |
+5,530
| New | +$109K | ﹤0.01% | 3493 |
|
2022
Q4 | – | Sell |
-3,178
| Closed | -$17K | – | 3015 |
|
2022
Q3 | $17K | Hold |
3,178
| – | – | ﹤0.01% | 3067 |
|
2022
Q2 | $29K | Sell |
3,178
-986
| -24% | -$9K | ﹤0.01% | 3070 |
|
2022
Q1 | $74K | Sell |
4,164
-224
| -5% | -$3.98K | ﹤0.01% | 2938 |
|
2021
Q4 | $249K | Buy |
4,388
+29
| +0.7% | +$1.65K | ﹤0.01% | 2767 |
|
2021
Q3 | $329K | Buy |
4,359
+1,793
| +70% | +$135K | ﹤0.01% | 2732 |
|
2021
Q2 | $432K | Buy |
2,566
+226
| +10% | +$38K | ﹤0.01% | 2633 |
|
2021
Q1 | $410K | Buy |
2,340
+126
| +6% | +$22.1K | ﹤0.01% | 2576 |
|
2020
Q4 | $454K | Buy |
2,214
+116
| +6% | +$23.8K | ﹤0.01% | 2482 |
|
2020
Q3 | $410K | Buy |
+2,098
| New | +$410K | ﹤0.01% | 2377 |
|